Foote Kelly D, Sanchez Justin C, Okun Michael S
Department of Neurosurgery, University of Florida, McKnight Brain Institute, Movement Disorders Center, Gainesville, Florida 32610, USA.
Neurosurgery. 2005 Feb;56(2):E415; discussion E415. doi: 10.1227/01.neu.0000147978.67424.42.
We report the intraoperative results, subsequent course, and 1-year follow-up evaluation of a patient with medication-refractory craniofacial dystonia for whom we planned bilateral globus pallidus internus (GPi) deep brain stimulation (DBS) implantation but delayed the left GPi DBS implantation because of robust intraoperative effects of right GPi DBS.
A 47-year-old patient had a 5-year history of progressively severe, bilateral craniofacial dystonia with blepharospasm (Meige's syndrome) that was refractory to medications and to botulinum toxin (A and B) injections. Blepharospasm interfered with his ability to perform his duties as a Special Forces soldier and ended his military career.
Under stereotactic guidance (magnetic resonance imaging and computed tomographic image fusion, Cosman-Roberts-Wells frame, and University of Florida surgical navigation software) and with detailed microelectrode mapping (four microelectrode passes), a DBS electrode was implanted in the right posteroventral GPi. Microelectrode recordings were taken to document electrophysiological activity of neurons in the region, and intraoperative macrostimulation was performed. The patient was followed up for 6 months with right unilateral GPi DBS, and later a left GPi DBS electrode was placed.
Although DBS for primary generalized dystonia is commonly performed by simultaneously implanting bilateral GPi electrodes, it may be reasonable in cases of refractory blepharospasm and/or craniofacial dystonia to use a staged procedure for implantation in selected patients. Additionally, the physiology, especially that encountered in the striatum, may help to elucidate the pathophysiological basis for refractory blepharospasm and Meige's syndrome. More cases will be needed to determine the significance of the results reported in this article.
我们报告了一名药物难治性颅面肌张力障碍患者的术中结果、后续病程及1年随访评估情况。对于该患者,我们计划进行双侧内侧苍白球(GPi)深部脑刺激(DBS)植入,但由于右侧GPi DBS的术中效果显著,推迟了左侧GPi DBS植入。
一名47岁患者有5年逐渐加重的双侧颅面肌张力障碍伴眼睑痉挛(Meige综合征)病史,对药物及肉毒毒素(A和B)注射均无效。眼睑痉挛影响了他作为特种部队士兵履行职责的能力,结束了他的军事生涯。
在立体定向引导下(磁共振成像与计算机断层扫描图像融合、Cosman-Roberts-Wells框架及佛罗里达大学手术导航软件),并通过详细的微电极图谱绘制(四个微电极通道),将一个DBS电极植入右侧后腹侧GPi。进行微电极记录以记录该区域神经元的电生理活动,并进行术中宏观刺激。对患者进行了6个月的右侧单侧GPi DBS随访,之后植入了左侧GPi DBS电极。
虽然原发性全身性肌张力障碍的DBS通常通过同时植入双侧GPi电极来进行,但对于难治性眼睑痉挛和/或颅面肌张力障碍患者,采用分期植入手术可能是合理的。此外,生理学,尤其是纹状体中遇到的生理学,可能有助于阐明难治性眼睑痉挛和Meige综合征的病理生理基础。需要更多病例来确定本文报道结果的意义。